Mutations modifying sporadic Alzheimer's disease age of onset

J.I. Vélez, F. Lopera, H.R. Patel, A.S. Johar, Y. Cai, D. Rivera, C. Tobón, A. Villegas, D. Sepulveda-Falla, S.G. Lehmann, S. Easteal, C.A. Mastronardi, M. Arcos-Burgos

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


The identification of mutations modifying the age of onset (AOO) in Alzheimer's disease (AD) is crucial for understanding the natural history of AD and, therefore, for early interventions. Patients with sporadic AD (sAD) from a genetic isolate in the extremes of the AOO distribution were whole-exome genotyped. Single- and multi-locus linear mixed-effects models were used to identify functional variants modifying AOO. A posteriori enrichment and bioinformatic analyses were applied to evaluate the non-random clustering of the associate variants to physiopathological pathways involved in AD. We identified more than 20 pathogenic, genome-wide statistically significant mutations of major modifier effect on the AOO. These variants are harbored in genes implicated in neuron apoptosis, neurogenesis, inflammatory processes linked to AD, oligodendrocyte differentiation, and memory processes. This set of new genes harboring these mutations could be of importance for prediction, follow-up and eventually as therapeutical targets of AD. © 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.
Original languageEnglish (US)
Pages (from-to)1116-1130
Number of pages15
JournalAmerican Journal of Medical Genetics, Part B: Neuropsychiatric Genetics
Issue number8
StatePublished - 2016
Externally publishedYes


Dive into the research topics of 'Mutations modifying sporadic Alzheimer's disease age of onset'. Together they form a unique fingerprint.

Cite this